Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Adelle who wrote (48476)	7/5/1999 7:01:00 AM
From: Sosmartinov	Respond to of 120523

My experience with biotechs has been almost the same.....after 3-4 yrs XOMA finally paid off just a little and mostly on recent speculation...the only way I have seen biotechs get anywhere predictably is when they have at least one cash cow ala AMGN and, as I've mentioned before, now CEPH. Also BGEN. JJJ has been touting IMCL for a while and it looks like it's finally making a move, eh?

To: Adelle who wrote (48476)	7/5/1999 5:24:00 PM
From: SMALL FRY	Read Replies (2) \| Respond to of 120523

VICL - I've been happy with my ST gains on this IT hold so far... I picked it up as replacement for my oil play GLBL... I'm always looking for long speculations on my IRA. So far I'm up more than 20% from the 30th of June... not bad for a biotech sector considered out of favor. <g> It's an IT play as I mentioned but I'm not above turning it into a ST play if it turns south... so far not bad. With the new Business Week coverage I'm looking for a little more... Home Run City? I sure hope so... Regards, SF